Meta Pixel

News and Announcements

Major Biopharmaceutical Signs to Up to MedAdvisor Patient Engagement Program

  • Published July 01, 2016 4:35PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

1st July 2016, ASX Announcement

Highlights:

  • MedAdvisor is collaborating with Bristol-Myers Squibb Australia (BMS) to deliver a patient engagement and education program concerning one of its products
  • Commencing shortly the 12-month patient engagement program (PEP) is being delivered via MedAdvisor’s medication management platform
  • This agreement will generate further PEP revenue for MedAdvisor
  • Provides further strong validation for MedAdvisor’s platform from a leading global biopharmaceutical company

MedAdvisors Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it will be collaborating with the Australian subsidiary of leading global pharmaceutical company, Bristol-Myers Squibb Company, to deliver a new patient engagement and education program.

To view the full announcement, please click on the button below.

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now